Hematocrit in Athletes: What Your Blood Really Tells You About Performance
Table of Contents
Introduction
Hematocrit in athletes is a parameter included in both basic and extended blood counts. It has been measured in almost every individual at some point, and clinicians encounter it constantly in everyday practice. However, hematocrit in athletes is interpreted very differently compared to the general population. Most patients have seen it in their own lab results — and in the majority of cases, it falls within the reference range and receives little further attention.
In athletic patients, however, hematocrit in athletes often behaves differently from what is seen in the general population, and its interpretation requires a more nuanced clinical understanding. That is why I wrote this article.
Hematocrit in athletes represents the percentage of your blood composed of red blood cells. It is one of the most frequently measured values in sports medicine, yet also one of the most consistently misread. A value that appears perfectly normal on a standard lab printout can be misleading — depending on how it is trending, the training context, and the accompanying iron markers. Understanding what hematocrit is actually telling you requires looking beyond the reference range and into the physiology behind the number.
Hematocrit in athletes represents the percentage of blood
Hematocrit tells you the proportion of your blood volume occupied by red blood cells, not the total number of them. This distinction matters enormously for athletes
Red blood cells carry hemoglobin, and hemoglobin binds oxygen. The main job of your cardiovascular system during exercise is to transport oxygen from the lungs to working muscle. It follows that having more oxygen-carrying red blood cells in circulation should improve performance — and in a direct manipulation study, it does. Research has consistently shown that oxygen transport capacity correlates directly with aerobic performance, and that artificially increasing the oxygen-carrying capacity of blood improves it [1].
Hematocrit tells you the proportion of your blood volume occupied by red blood cells, not the total number of them. This distinction matters enormously for athletes. It is a concentration measure — describing red blood cells relative to total blood volume. Increase your plasma volume, the watery portion of blood, and your hematocrit drops even if your actual red cell mass stays the same or increases. This is exactly what happens with endurance training.
In my athletic patients, I occasionally observe decreases in hemoglobin and hematocrit. However, this does not represent true anemia. As we will see in the next section, it is most often a physiological phenomenon. My athletic patients are often well aware of the risk of iron deficiency, particularly female athletes who may have heavy menstrual bleeding. This makes understanding this distinction especially important for them.
The Sports Anemia Paradox: Why Hematocrit in Athletes Appears Lower
Trained endurance athletes typically have lower hematocrit values than sedentary individuals. Regular physical training causes plasma volume to expand by approximately 10–20% [2]. Because plasma volume expands faster than red cell mass increases, the resulting blood test appears to show “low” hemoglobin or hematocrit — a phenomenon historically called “sports anemia.”
This label is a misnomer. It is not true anemia. The absolute mass of red blood cells and hemoglobin in circulation is actually greater in trained athletes than in sedentary individuals [1]. The decrease in hematocrit reflects a dilutional effect, not a reduction in red cell mass. Research confirmed this directly: the decreased hemoglobin levels observed in endurance athletes was largely a dilutional effect caused by expanded plasma volume, with male athletes showing plasma volumes approximately 37.5% higher than sedentary controls [3].
In many trained endurance athletes, this reflects a beneficial plasma-volume adaptation rather than true anemia. The expanded plasma volume improves blood flow, reduces viscosity, and enhances oxygen delivery at the tissue level by allowing the heart to pump greater stroke volumes with less resistance. When the cause is confirmed as dilutional, no treatment is required or appropriate [2]. True iron deficiency or other pathology can still coexist, which is why clinical evaluation should accompany any low result.
Patients are naturally concerned when they see a drop in hemoglobin and hematocrit. In these situations, I recommend checking the full iron panel, particularly ferritin. If ferritin is not low, true iron deficiency is unlikely — though clinical context should always be considered.
Normal Ranges and Hematocrit in Athletes: Same Numbers, Different Meaning
Standard clinical reference ranges for hematocrit are approximately 40.7–50.3% for males and 36.1–44.3% for females, derived primarily from general population samples. Hematocrit reference ranges are defined statistically so that approximately 95% of the general population falls within them. The key insight for athletes is not that they need entirely different reference ranges — research on elite athletes shows that their basal hematocrit distributions overlap considerably with the general population — but that the interpretation of any value within those ranges is highly context-dependent in a trained individual.
A large-scale study of 3,588 elite athletes across 32 sport disciplines — with over 14,000 blood samples collected between 2011 and 2020 — found that basal hematocrit intervals in elite athletes were very similar to general population intervals: approximately 35.6–45.2% in women and 40.0–50.4% in men, with no statistically significant departure from standard ranges for hematocrit itself [4]. The critical differences lie in sport-specific patterns and in what a given value means at different points in training. Among professional male cyclists specifically, mean hematocrit was 45.0 ± 2.9%, with female cyclists averaging 40.7 ± 2.7% [5].
In highly trained male footballers, the physiological hematocrit range has been measured at 42.3 ± 2.74%, spanning from approximately 36.8 to 47.8% across two standard deviations [6]. The critical finding from that study — one that every athlete and coach should understand — was that athletes in the lowest hematocrit quintile (below 40%) demonstrated higher aerobic working capacity and VO2max than those in higher quintiles [6]. In well-trained athletes under normal conditions, a lower resting hematocrit often reflects greater training adaptation, not a deficit.
A second important finding from the same research: in that study, higher hematocrit values (above 44.6%) were associated with overtraining scores and possible iron-related problems [6]. High hematocrit in an athlete is not always a good sign.
My patients often assume that the higher the hemoglobin, the better. However, from a clinical and performance perspective in athletes, a lower hematocrit — and correspondingly lower hemoglobin concentration — can actually reflect a beneficial adaptation driven by plasma volume expansion, even though it often causes concern. Importantly, it is not the lower hemoglobin itself that is beneficial, but the expanded plasma volume and improved circulation that accompany it; total hemoglobin mass is often increased despite a lower concentration.
A more appropriate measure for athletes would be total hemoglobin mass. Unfortunately, this cannot be reliably measured in routine clinical practice, as we do not know an individual’s true blood volume. As a result, we have to rely on indirect markers — measuring hemoglobin and hematocrit, and assessing iron parameters to interpret the situation indirectly.
Total hemoglobin mass can be measured using the carbon monoxide rebreathing method, which estimates the total amount of hemoglobin in circulation by tracking the uptake of a small, controlled dose of carbon monoxide. However, this technique is primarily used in research and elite sports settings. It is not part of routine clinical practice in Finland, and in practical terms, it is rarely accessible to athletes and patients outside specialized environments.
How Training Raises — and Lowers — Your Hematocrit
Training exerts competing pressures on hematocrit simultaneously, which is why the relationship between fitness and hematocrit is nonlinear and context-dependent.
Plasma volume expansion is the dominant effect of sustained endurance training. Within days of beginning an intensive training block, plasma volume rises faster than red cell production can keep pace, driving hematocrit down.
Erythropoiesis stimulation — the production of new red blood cells — follows over days to weeks as the body responds to repeated bouts of oxygen demand. This is driven by erythropoietin (EPO), a hormone produced by the kidneys in response to relative oxygen deficiency in tissues. The result is a gradual increase in total red cell mass, even as hematocrit remains suppressed by the proportionally larger plasma expansion. Clinically, I see patients with chronic kidney disease in whom reduced endogenous EPO production leads to anemia, requiring treatment with EPO. Its use, however, is typically managed under the supervision of a nephrologist.
The long-term outcome: a trained athlete has more red blood cells and more hemoglobin in absolute terms, better cardiac output, and a lower resting hematocrit than an untrained individual — all of which combine to produce superior oxygen delivery to working muscle. As research has established, oxygen delivery, rather than skeletal muscle oxygen extraction, is the primary limiting factor for VO2max [7]. Over the long term, hematocrit typically decreases slightly from baseline in athletic patients. As a result, they often present with mildly lower hematocrit values overall
As a side note, erythropoietin (EPO) is relatively well known among the Finnish public, largely due to the 2001 Lahti World Championships doping scandal involving Finnish cross-country skiers. This illustrates how EPO increases red blood cell mass, hematocrit, and oxygen-carrying capacity. Interestingly, the athletes were not caught directly for EPO use, but for using a plasma expander — hydroxyethyl starch (HES) — which was detected in blood samples and revealed attempts to mask blood manipulation.
Altitude Training and the Hematocrit Effect
Elite athletes have long used altitude training to drive up red cell mass and, with it, hematocrit and VO2max. The physiological logic is sound: at altitude, reduced oxygen partial pressure stimulates EPO production, which accelerates erythropoiesis and increases total hemoglobin mass [8].
The research is clear on how much altitude, and for how long. A meta-analysis and subsequent studies found that total hemoglobin mass increases at approximately 1.1% per 100 hours of altitude exposure using a live high–train low (LH-TL) protocol [8]. An anticipated increase of approximately 3.4% in total hemoglobin mass was observed after two weeks of live high–train high training above 2,100 m [8].
The optimal altitude window for sea-level performance gains appears to be 2,085–2,454 m. Research randomizing 48 collegiate distance runners to one of four living altitudes found that 3,000-metre time trial performance improved significantly only in groups living at the middle two altitudes — not at 1,780 m (insufficient hypoxic stimulus) or 2,800 m (where competing negative effects appear) [9].
The practical threshold for stimulating meaningful erythropoiesis is approximately 1,600 m, with more robust responses beginning above 2,100–2,500 m [8].
This physiological increase in EPO is perfectly allowed, in contrast to the use of exogenous EPO for doping. Finnish cross-country skiers, like other elite endurance athletes, routinely use altitude training to stimulate this natural response and enhance oxygen-carrying capacity.
The Performance Impact: What Hematocrit Changes Actually Do
Research using recombinant human erythropoietin (rHuEPO) — a drug that directly increases hematocrit and hemoglobin — provides the clearest window into how manipulating hematocrit affects performance. A 2025 systematic review of 10 studies on well-trained endurance athletes found that rHuEPO consistently improved VO2max by 2.6–10% and peak power output by 2.7–5.8%, regardless of the total dose administered [10].
These are large effects. A 5% improvement in VO2max for a competitive distance runner translates directly to race time improvements that separate podium positions from the field.
The mechanism is straightforward: more red blood cells mean more hemoglobin, more hemoglobin means more oxygen transported per heartbeat, and more oxygen delivered to working muscle per unit time means a higher sustainable exercise intensity. This is why total hemoglobin mass — which hematocrit only partially reflects — correlates directly with aerobic performance across athlete populations [1].
But artificially maximising hematocrit has a hard ceiling: blood viscosity. As hematocrit rises, blood thickens and becomes harder to pump. The relationship between hematocrit and oxygen delivery is not linear but parabolic — too low means insufficient oxygen-carrying capacity, too high means circulation slows to the point that delivery suffers [11]. Optimal hematocrit theory, reviewed comprehensively in 2024, identifies the ideal hematocrit for oxygen transport as lying in the 0.3–0.5 range under resting conditions, with higher values potentially beneficial during extreme exertion [11]. The hematocrit/viscosity ratio is the physiologically meaningful parameter, not hematocrit alone.
This is one reason EPO and blood doping have been linked to serious thrombotic and cardiovascular harm, and possibly to athlete deaths — though direct attribution of specific fatalities to EPO remains historically difficult to establish with certainty. The UCI’s 50% hematocrit limit in professional cycling was implemented as a regulatory health safeguard, not as a universal biological threshold; above 50%, the risk of thrombotic events — particularly during sleep when cardiac output falls — was considered unacceptable, even if the exact danger point varies between individuals.
For example, patients with polycythemia vera — a myeloproliferative disorder characterized by excessive production of red blood cells — have an increased risk of thrombosis and are often treated with aspirin. However, the first-line treatment — at least in Finland — is regular phlebotomy. This differs from standard blood donation, and the blood removed in this context is generally not used for transfusion.
When High Hematocrit Signals a Problem
In athletes, a hematocrit that sits persistently at the upper end of the normal range — or above it — can indicate several issues worth investigating:
Iron deficiency without frank anemia. In the early stages of iron depletion, hemoglobin and hematocrit can remain within normal limits while ferritin is already critically low and red cell indices are beginning to deteriorate. The standard teaching is that iron deficiency, once established, lowers hematocrit — but the early stage can be missed entirely if only hematocrit is checked. A normal hematocrit does not rule out iron deficiency. Always cross-reference with ferritin, MCV, and hemoglobin concentration together [6].
Dehydration. Plasma volume contracts rapidly with fluid loss, concentrating red cells and raising hematocrit artificially. A hematocrit value taken after a hard training session in the heat can be several percentage points above true resting levels and tells you nothing meaningful about your red cell mass.
Overtraining. The study of professional footballers cited earlier found a positive correlation between high hematocrit (above 44.6%) and overtraining scores [6]. The mechanism is likely relative plasma contraction due to inadequate recovery and fluid balance disruption.
Polycythemia. In rare cases, genuinely elevated hematocrit reflects primary or secondary polycythemia — pathological overproduction of red blood cells requiring medical evaluation. In a recreational or masters athlete presenting with persistent values above 52% (males) or 48% (females) without a training or altitude explanation, further investigation is warranted.
In my clinical work, I often encounter elevated hemoglobin and hematocrit in dehydrated patients. This can often serve as an early warning sign of dehydration. In these situations, it is also standard to assess kidney function and electrolytes, among other parameters, and to recheck hemoglobin after correcting fluid balance.
Summary
Hematocrit is a commonly measured laboratory value, but in athletes it is often misinterpreted. It reflects the proportion of blood volume occupied by red blood cells, not total red cell mass or true oxygen-carrying capacity — a distinction that is crucial in sports medicine.
In endurance athletes, hematocrit and hemoglobin often decrease due to plasma volume expansion, a normal and beneficial adaptation rather than true anemia. This so-called “sports anemia” reflects improved circulation and oxygen delivery, even though it may raise concern. Proper interpretation therefore requires context, including training status and iron parameters such as ferritin.
While reference ranges are similar to the general population, their meaning differs in athletes. Lower values may reflect adaptation, whereas higher values can indicate dehydration, overtraining, or pathology such as Polycythemia vera.
Ultimately, hematocrit is not a standalone performance marker — its value lies in understanding the physiology behind it.
References
- https://pmc.ncbi.nlm.nih.gov/articles/PMC3824146/
- https://pubmed.ncbi.nlm.nih.gov/9610226/
- https://pubmed.ncbi.nlm.nih.gov/1874243/
- https://doi.org/10.3390/ijerph19053059
- https://pubmed.ncbi.nlm.nih.gov/12383076/
- https://pubmed.ncbi.nlm.nih.gov/11081466/
- https://pubmed.ncbi.nlm.nih.gov/10647532/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC5904371/
- https://pubmed.ncbi.nlm.nih.gov/24157530/
- https://doi.org/10.3390/sports13030078
- https://pubmed.ncbi.nlm.nih.gov/38813609/
